SEC Form 4 · accession 0000899243-16-032310
CRISPR Therapeutics AG · CRSP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
N Anthony Coles
Director
Period of report
Oct 24, 2016
Accepted (ET)
Oct 26, 2016 · 6:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001674416
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 24, 2016 | A | 35,000 | $14.00 | A | 70,000 | I | By wife |
| Common Stock | Oct 24, 2016 | A | 35,000 | $14.00 | A | 70,000 | I | By Coles Family Trust |
Table II — derivative securities
No Table II lines on this filing.